Asian Journal of Research and Reports in Endocrinology

Prediabetic Risk and Disease Burden: A Cross-sectional Survey of an Ayurveda Hospital

Asha S. A. *

PG Department of Swasthavritta, Shree Jagadguru Gavisiddeshwara Ayurveda Medical College and Hospital, Koppal, Karnataka, India.

M. B. Kavita

PG Department of Swasthavritta, Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, Karnataka, India.

*Author to whom correspondence should be addressed.

---

Abstract

Aims: To know the prevalence of prediabetes and diabetes among the health seekers visiting to an Ayurveda hospital, the survey study was conducted. Prediabetes is a serious health condition where blood sugar levels are higher than normal, but not high enough yet to be diagnosed as type 2 diabetes. Diabetes is one of the largest global health emergencies of this century, ranking among the 10 leading causes of mortality. Early screening is as essential as early diagnosis and treatment.

Study Design: A cross-sectional survey study.

Place and Duration of the Study: Department of Swasthavritta, Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, between January 2020 and December 2020.

Methodology: Laboratory registers accessed from Sri Dharmasthala Manjunatheshwara Ayurveda Medical College and Hospital, Hassan, Karnataka. Guidelines of Centers for Disease Control and Prevention was used to detect prediabetes and diabetes.

Results: The preliminary report on the survey study conducted for one year during 2020 showed among the subjects tested for blood and urine sugars, around 13% were prediabetics and 27% were diabetics.

Conclusion: Awareness among public and healthcare professionals regarding etiological factors, risk factors are crucial in finding out prediabetics. People who visit the hospital to improve the quality of life or for any treatments must be encouraged to undergo screening for non-communicable diseases such as diabetes

Keywords: Prevalence, prediabetes, diabetes, risk factor, survey, ayurveda hospital

---

---

---

References

Khetan AK, Rajagopalan S. ‘Prediabetes’, Canadian Journal of Cardiology. 2018;34 (5):615–623.

DOI:10.1016/j.cjca.2017.12.030.

Tabák AG et al. Prediabetes: A high-risk state for diabetes development. The Lancet. 2012;379(9833): 2279–2290. DOI:10.1016/s0140-6736(12)60283-9.

Mohan V, Pradeepa R. Epidemiology of type 2 diabetes in India’, Indian Journal of Ophthalmology. 2021;69(11):2932. DOI:10.4103/ijo.ijo_1627_21.

Zand A, Ibrahim K, Patham B. Prediabetes: Why should we care?. Methodist DeBakey Cardiovascular Journal. 2018;14(4):289. DOI:10.14797/mdcj-14-4-289.

Aroda VR, Ratner R. Approach to the patient with prediabetes. The Journal of Clinical Endocrinology & amp; Metabolism. 2008;93(9):3259–3265. DOI:10.1210/jc.2008-1091.

Tsilingiris D, Vallianou NG, Dalamaga M. Prediabetes screening: Questionable benefits in the Golden Years’, Metabolism Open. 2021;10:100091. DOI:10.1016/j.metop.2021.100091.

Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, Magliano DJ, Selvin E. Global prevalence of prediabetes. Diabetes Care. 2023;dc222376.

Diabetes tests. Centers for Disease Control and Prevention; 2023.

Available:https://www.cdc.gov/diabetes/basics/getting-tested.html (Accessed: 30 July 2023).

Anjana RM et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR–INDIAB population-based cross-sectional study’, The Lancet Diabetes & Endocrinology. 2017;5(8):585–596.

DOI:10.1016/s2213-8587(17)30174-2.

Tabák AG et al. Prediabetes: A high-risk state for diabetes development. The Lancet. 2012;379(9833):2279–2290.

DOI:10.1016/s0140-6736(12)60283-9.

Mohan V, Pradeepa R. Epidemiology of type 2 diabetes in India. Indian Journal of Ophthalmology. 2021;69(11):2932. DOI:10.4103/ijo.ijo_1627_21.

Aroda VR, Ratner R. Approach to the patient with Prediabetes. The Journal of Clinical Endocrinology & Metabolism. 2008;93(9):3259–3265. DOI:10.1210/jc.2008-1091.

Tsilingiris D, Vallianou NG, Dalamaga M. Prediabetes screening: Questionable benefits in the Golden Years’, Metabolism Open. 2021;10:100091. DOI:10.1016/j.metop.2021.100091.

Dimitrios Tsilingiris, Natalia G. Vallianou, Maria Dalamaga,Prediabetes screening:Questionable benefits in the golden years, Metabolism Open. 2021;10:100091,ISSN 2589-9368,

Available:https://doi.org/10.1016/j.metop.2021.100091.

Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69(11):2932-2938.

DOI:10.4103/ijo.IJO_1627_21.PMID: 34708726; PMCID: PMC8725109.

Ogbole FA, Harold BA. Association of undiagnosed pre-diabetes and type-2 diabetes mellitus with interleukin-2 mRNA expression among adults in Bayelsa State, Nigeria. IJRR. 2023;10(5): 210-5.

Shaheen M, Schrode KM, Tedlos M, Pan D, Najjar SM, Friedman TC. Racial/ethnic and gender disparity in the severity of NAFLD among people with diabetes or prediabetes. Frontiers in Physiology. 2023;14:1076730.